“It’s Raining Money on Ethereum as Corporate Downpour Intensifies — Cosmos Health Pours In $300 Million”

Cosmos Health Inc. (COSM), a global healthcare group specializing in nutraceuticals, pharmaceuticals, and medical devices, has struck a major deal with a U.S.-based institutional investor to raise up to $300 million. The funding will come through senior secured convertible promissory notes and will power the company’s newly unveiled Ethereum (ETH) digital asset treasury reserve strategy.

Under this plan, Cosmos Health will accumulate ETH to boost long-term shareholder value, targeting growth in ETH-per-share. All ETH will be securely custodied and staked via BitGo Trust Company, a leading institutional-grade provider.

This treasury strategy is part of Cosmos Health’s broader digital transformation, which also explores blockchain for supply chain traceability, global consumer engagement, and wellness incentive programs. The company also plans to deploy yield-generating strategies to maximize returns from its ETH holdings.

CEO Greg Siokas called the move a strategic milestone, offering shareholders direct exposure to Ethereum while also securing growth capital for product development, R&D, and a planned entry into U.S. manufacturing.

At least 72.5% of net proceeds from each funding tranche will go directly into ETH reserves, with the rest allocated to working capital and other strategic initiatives — a clear signal of the company’s long-term commitment to innovation and blockchain adoption.

#ETHnewATHcomingSoon
#KeepMovingForward